USD 14.27 billion
Global Biodefense Market Size, Share, Growth Analysis, By Type(Anthrax, Smallpox), By Application(Hospitals and clinics, ambulatory care centres and others) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2213 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
63 |
Figures:
75
Global Biodefense Market Insights
Biodefense Market size was valued at USD 14.27 billion in 2021 and is poised to grow from USD 15 billion in 2022 to USD 22.33 billion by 2030, growing at a CAGR of 5.1% during the forecast period (2023-2030).
The global biodefense market has witnessed significant growth and transformation in recent years, driven by the increasing threats posed by biological agents and the need for effective preparedness and response measures. Biodefense refers to a range of activities and technologies aimed at countering the potential risks associated with bioterrorism, pandemics, and other biological emergencies. The market encompasses various sectors, including vaccines, therapeutics, detection and diagnostics, and protective equipment. The demand for biodefense solutions has surged due to the growing recognition of the potential catastrophic consequences of biological attacks and outbreaks. Governments around the world are investing heavily in biodefense capabilities, bolstering the market's growth. Additionally, advancements in technology and the increasing focus on research and development have led to the introduction of innovative and sophisticated biodefense products. Technological advancements, including genomics, synthetic biology, and data analytics, are driving the evolution of biodefense solutions, providing enhanced capabilities in detection, characterization, and mitigation of biological threats. Furthermore, collaborations between governments, defense agencies, and private sector entities have fostered the development of comprehensive biodefense strategies and bolstered market expansion. However, challenges such as regulatory hurdles, high costs associated with research and development, and the complex nature of biodefense threats pose obstacles to market growth. Nevertheless, the global market is poised for substantial expansion in the coming years as nations continue to prioritize and invest in strengthening their capabilities to mitigate and respond effectively to biological emergencies.
US Biodefense Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Anthrax
Fastest Growth
Anthrax
Growth Rate
5.1% CAGR
Global Biodefense Market ($ Bn)
Country Share for North America Region (%)
Global Biodefense Market By Type ($ Bn)
Global Biodefense Market By Type (%)
To get more reports on the above market click here to Buy The Report
Global Biodefense Market Segmental Analysis
Global Biodefense Market is segmented by type, application, and region. Based on type, the market can be segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear and Others. Based on application, the market is segmented into Hospitals and clinics, ambulatory care centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Biodefense Market Analysis by Type
The dominant segment in the global biodefense market is the Anthrax segment. Anthrax is considered a significant bioterrorism threat, and therefore, investments in anthrax vaccines, therapeutics, and detection systems have been substantial. The prevalence of anthrax as a potential biological weapon has led to a strong focus on developing robust countermeasures and preparedness strategies, making the Anthrax segment the leading sector in the biodefense market.
On the other hand, the fastest-growing segment in the global biodefense market is the Radiation/Nuclear segment. With the increasing concerns over radiological and nuclear threats, governments and organizations worldwide are investing significantly in technologies and solutions for detection, protection, and decontamination. The escalating risks associated with nuclear accidents, illicit nuclear activities, and the potential use of radiation as a weapon have propelled the demand for advanced radiation/nuclear biodefense solutions, making it the fastest-growing segment in the market.
Biodefense Market Analysis by Application
The dominant segment in the global biodefense market based on application is the Hospitals and Clinics segment. Hospitals and clinics play a vital role in biodefense preparedness and response, serving as primary healthcare facilities for the management and treatment of individuals exposed to biological agents. These facilities require robust biodefense infrastructure, including specialized equipment, diagnostic tools, and trained personnel, making the Hospitals and Clinics segment the leading sector in the market.
Meanwhile, the fastest-growing segment in the global biodefense market based on application is the Ambulatory Care Centers segment. Ambulatory care centers, also known as outpatient facilities, are experiencing rapid growth due to the increasing emphasis on community-based healthcare services and the need for decentralized biodefense capabilities. Ambulatory care centers provide timely and accessible care, including diagnostics, vaccinations, and early detection of potential biological threats. The rising demand for efficient and agile healthcare delivery models has led to the significant growth of the Ambulatory Care Centers segment in the biodefense market.
Global Biodefense Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Biodefense Market Regional Insights
North America dominated the global biodefense market. North America holds a significant market share due to its well-established healthcare infrastructure, robust research and development capabilities, and strong emphasis on national security. The region has witnessed substantial investments in biodefense technologies, including vaccines, therapeutics, and detection systems, driven by proactive government initiatives, collaborations with industry stakeholders, and a high level of preparedness against bioterrorism threats.
Asia Pacific is the fastest-growing segment in the global biodefense market. Asia Pacific has experienced significant growth in recent years due to the increasing awareness of biological threats, rising healthcare expenditure, and government initiatives aimed at strengthening biodefense capabilities. Countries in the region, such as China, India, Japan, and South Korea, have made substantial investments in research and development, resulting in the development of innovative biodefense solutions. Moreover, the region's large population and high vulnerability to infectious diseases have further accelerated the demand for biodefense products and technologies, making Asia Pacific the fastest-growing market segment in the biodefense sector.
Global Biodefense Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Biodefense Market Dynamics
Biodefense Market Drivers
Increasing recognition of the potential catastrophic consequences of biological threats
- One key driver of the global biodefense market is the increasing recognition of the potential catastrophic consequences of biological threats. Governments, defense agencies, and healthcare organizations worldwide are investing heavily in biodefense capabilities to mitigate the risks posed by bioterrorism, pandemics, and other biological emergencies.
Biodefense Market Restraints
High costs associated with research and development of biodefense solutions
- A notable restraint for the Global Biodefense Market is the high costs associated with research and development of biodefense solutions. Developing effective vaccines, therapeutics, and detection systems requires substantial investment in research, clinical trials, and regulatory approvals. The complex nature of biodefense threats adds to the challenges, making it difficult to achieve cost-effective solutions and hindering market growth.
Request Free Customization of this report to help us to meet your business objectives.
Global Biodefense Market Competitive Landscape
The competitive landscape of the global biodefense market is characterized by intense competition among various stakeholders, including government organizations, research institutions, and private sector entities. The market is witnessing a significant influx of investments, driving innovation and the development of advanced biodefense technologies. Collaborations and partnerships between industry players and government agencies are common, facilitating knowledge exchange, resource sharing, and the development of comprehensive biodefense strategies. Additionally, regulatory frameworks and standards play a crucial role in shaping the competitive dynamics of the market, ensuring the safety and efficacy of biodefense products and solutions. The market's competitive intensity is further fueled by the constant evolution of biological threats and the need for continuous research and development to stay ahead of emerging risks.
Biodefense Market Top Player’s Company Profiles
- Dynavax Technologies Corporation (US)
- SIGA Technologies (US)
- Elusys Therapeutics Inc. (US)
- Ichor Medical Systems (US)
- Dynport Vaccine Company (US)
- Cleveland Biolabs (US)
- Bavarian Nordic (Denmark)
- Ology Bioservices (US)
- Alnylam Pharmaceuticals Inc. (US)
- Evolva (Switzerland)
- BioCryst Pharmaceuticals Inc. (US)
- PharmAthene Inc. (US)
- Profectus Biosciences Inc. (US)
- NanoViricides Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Sanofi Pasteur (France)
- GlaxoSmithKline (UK)
Biodefense Market Recent Developments
- In June 2022, Emergent BioSolutions Inc. (NYSE: EBS) made an announcement stating that the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) has been accepted for review by the United States Food and Drug Administration (FDA). This indicates progress in the regulatory process for AV7909, a vaccine developed to provide protection against anthrax.
- In May 2022, Emergent BioSolutions Inc. disclosed that it had reached a definitive agreement with Chimerix, Inc. to acquire exclusive worldwide rights to TEMBEXA (brincidofovir). TEMBEXA is the first antiviral treatment approved by the United States Food and Drug Administration (FDA) for all age groups in the management of smallpox. This acquisition signifies Emergent BioSolutions' commitment to expanding its portfolio of antiviral treatments for critical infectious diseases.
Global Biodefense Key Market Trends
- One key market trend in the global biodefense market is the increasing focus on the development of advanced diagnostic technologies. There is a growing emphasis on the rapid and accurate detection of biological agents to enable early intervention and effective response during biodefense incidents. Innovative diagnostic tools, such as point-of-care testing devices and molecular diagnostics, are being developed to enhance the speed and accuracy of identifying potential biological threats. This trend aims to strengthen surveillance systems and improve the overall preparedness and response capabilities in biodefense scenarios.
Global Biodefense Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global biodefense market analysis, the market is witnessing significant growth driven by the increasing recognition of the potential catastrophic consequences of biological threats. Governments, defense agencies, and healthcare organizations are investing heavily in biodefense capabilities to mitigate the risks posed by bioterrorism, pandemics, and other biological emergencies. The market encompasses various sectors such as vaccines, therapeutics, detection and diagnostics, and protective equipment. Technological advancements, collaborations, and research and development efforts are driving the evolution of biodefense solutions. However, high costs associated with research and development pose a restraint to market growth. North America dominates the market, while the Asia Pacific region exhibits the fastest growth. Key trends include the development of advanced diagnostic technologies for rapid and accurate detection of biological agents. Overall, the global market is poised for sustained expansion as the world prioritizes proactive measures in safeguarding public health and national security.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 14.27 billion |
| Market size value in 2031 | USD 22.33 billion |
| Growth Rate | 5.1% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Biodefense Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Biodefense Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Biodefense Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Biodefense Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Biodefense Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Biodefense Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Biodefense Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
